輸入代號或公司名稱後按 Enter
4911

德英

-0.10 (-0.35%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
28.707成交張數21.26本益比2.09股價淨值比6.85%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.12-79.5%1.250.0822.9%0.87%9.91%
2026Q10.21-59.9%1.700.1546.2%1.59%12.97%
2025Q40.39-14.4%2.020.2739.5%2.99%15.80%
2025Q30.5332.6%2.080.3645.3%4.09%16.81%
2025Q20.5764.0%1.950.3948.9%4.52%16.42%
2025Q10.5387.8%1.730.3745.6%4.29%14.39%
2024Q40.4570.2%1.480.3143.5%3.82%12.78%
2024Q30.4023.0%1.300.2844.4%3.51%11.54%
2024Q20.3543.4%1.220.2439.5%3.02%11.20%
2024Q10.2829.6%1.120.2035.5%2.54%10.34%
2023Q40.2794.2%1.050.1837.7%2.44%9.96%
2023Q30.32300.4%0.920.2246.9%3.03%8.91%
2023Q20.240.680.1737.5%2.34%6.73%
2023Q10.220.400.1537.0%2.16%3.97%
2022Q40.140.110.1031.8%1.39%1.07%
2022Q30.08-0.160.0629.3%0.85%-1.60%
2022Q2-0.04-0.29-0.03-38.0%-0.43%-2.89%
2022Q1-0.07-0.32-0.05-69.1%-0.74%-3.13%
2021Q4-0.13-0.29-0.09-171.5%-1.28%-2.87%
2021Q3-0.05-0.19-0.03-40.7%-0.44%-1.85%
2021Q2-0.06-0.19-0.05-127.9%-0.66%-1.88%
2021Q1-0.05-0.20-0.03-40.5%-0.47%-1.94%
2020Q4-0.03-0.21-0.02-20.4%-0.27%-2.01%
2020Q3-0.05-0.23-0.03-34.4%-0.48%-2.19%
2020Q2-0.07-0.26-0.05-99.8%-0.72%-2.53%
2020Q1-0.06-0.28-0.04-97.7%-0.55%-2.66%
2019Q4-0.05-0.34-0.03-65.0%-0.44%-3.20%
2019Q3-0.08-0.39-0.06-116.5%-0.82%-3.65%
2019Q2-0.09-0.38-0.06-112.9%-0.84%-3.45%
2019Q1-0.12-0.38-0.08-384.4%-1.10%-3.44%
2018Q4-0.10-0.33-0.07-397.0%-0.88%-3.01%
2018Q3-0.07-0.49-0.05-1104.9%-0.63%-4.33%
2018Q2-0.09-375.5%-0.61-0.06-12582.0%-0.83%-5.49%
2018Q1-0.07-0.49-0.05-7651.5%-0.66%-4.34%
2017Q4-0.25-0.61-0.17-863.6%-2.20%-5.32%
2017Q3-0.20-0.38-0.14-722.5%-1.79%-3.33%
2017Q20.03-0.270.0217.0%0.31%-2.30%
2017Q1-0.19-0.36-0.13-407.5%-1.64%-3.10%
2016Q4-0.02-0.21-0.02-20.8%-0.21%
2016Q3-0.09-0.06-104.8%-0.77%